参考文献 References
[1] Jiang X, Fischer D, Chen X, et al. Evidence for follicle-stimulating hormone receptor as a functional trimer.J Biol Chem,2014;289
(20)
: 14273-14282.
[2] Dias, J.A. Molecular,structural,and cellular biology of follitropin and follitropin receptor .Vitam Horm ,2002 ;64
: 249 -322 .
[3] Mayorga M, Gromoll J, Behre H, et al. Ovarian response to follicle-stimulating hormone(FSH) stimulation depends on the FSH receptor genotype.J Clin Endocrinol Metab,2000;85
(9)
: 3365-3369.
[4] Themmen APN, Huhtaniemi, IT. Mutations of gonadotropins and gonadotropin receptors:elucidating the physiology and pathophysiology of pituitary-gonadal function .Endocr Rev ,2000 ;21
: 551-583.
[5] Ryan RJ, Charlesworth MC, McCormick DJ, et al. The glycoprotein hormones:recent studies of structure-function relationships.FASEB J,1988;2
(11)
: 2661-2669.
[6] Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors:Elucidating the physiology and pathophysiology of pituitary-gonadal function.Endocr Rev,2000;21
: 551-583.
[7] Szkudlinski M. New frontier in glycoprotein hormones and their receptors structure-function.Front Endocrinol,2015;6
: 155.
[8] Nunez M, Sanders J, Fumaniak J, et al. Glycosylation pattern analysis of glycoprotein hormones and their receptors.J Mol Endocrinol,2017;58
(1)
: 25-41.
[9] Rose M, Gaines D, Balen A, et al. Definition and measurement of follicle stimulating hormone.Endocr Rev,2000;21
(1)
: 5-22.
[10] Kristin M.Fox, James A.Dias, and Patrick Van Roey. Three-Dimensional Structure of Human Follicle-Stimulating Hormone .Mol Endocrinol ,2000 ;15
(3 )
: 378-389.
[11] Alevizaki M, Huhtaniemi L. Structure-function relationships of glycoprotein hormones; lessons from mutations and polymorphisms of the thyrotrophin and gonadotrophin subunit genes.Hormones,2002;1
(4)
: 224-232.
[12] Amla Kuechler, Berthold P Hauffa, Angela Ko ninger. An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor(FSHR) gene and causes FSH resistance .Eur J Human Genet ,2010 ;18
: 656-661.
[13] Ulloa-Aguirre A, Zarinan T. The follitropin receptor: matching structure and function.Mol Pharmacol,2016;90
(5)
: 596-608.
[14] Papadimitriou K, Kountourakis P, Kottorou AE. Follicle-stimulating hormone receptor(FSHR): a promising tool in oncology?.Mol Diagn Ther ,2016 ;20
(6 )
: 523 -530 .
[15] Meher BR, Dixit A, Bousfield GR, et al. Glycosylation effects on FSH-FSHR interaction Dynamics:A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations .Plos One ,2015 ;10
(9 )
: - .
[16] Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor.Nature,2005;433
(7023)
: 269-277.
[17] Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function.Endocr Rev,2000;21
: 551-583.
[18] Huhtaniemi I, Alevizaki M. Gonadotrophin resistance.Best Pract Res Clin Endocinol Metab,2006;20
: 561-576.
[19] Ulloa-Aguirre A, Timossi C, Barrios-de-Tomasi J,et al. Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone:Studies derived from in vitro and in vivo models .Biol Reprod ,2003 ;69
: 379-389.
[20] Gromoll J, Simoni M. Genetic complexity of FSH receptor function.Trends Endocrinol Metab,2005;16
: 368-373.
[21] Sanchez-Cardenas, C. & Hernandez-Cruz, A. GnRH-Induced [Ca2+]isignalling patterns in mouse gonadotrophs recorded from acute pituitary slices in vitro .Neuroendocrinol ,2010 ;91
: 239 -255 .
[22] Lindsey K. Roper, Joseph S. Briguglio, Chantell S. Evans. Sex-specific regulation of follicle-stimulating hormone secretion by synaptotagmin 9 .Nat Commun ,2015 ;6
: 8645 - .
[23] Liu X, Chan H, Ding G, et al. FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca2+/CREB pathway.Aging Cell,2015;14
: 409-420.
[24] Visser JA, Schipper I, Laven JS. Anti-müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.Nat Rev Endocrinol,2012;8
(6)
: 331-341.
[25] Mizunuma H, Takagi T, Honjyo S, Ibuki Y, Igarashi M. Clinical pharmacodynamics of urinary follicle-stimulating hormone and its application for pharmacokinetic simulation program.Fertil Steril,1990;53
(3)
: 440-445.
[26] Qiu Q, Kuo A, Todd H, Dias JA, Gould JE, Overstreet JW, Lasley BL. Enzyme immunoassay method for total urinary follicle-stimulating hormone (FSH) beta subunit and its application for measurement of total urinary FSH.Fertil Steril,1998;69
(2)
: 278-285.
[27] Howles CM. Role of LH and FSH in ovarian function.Mol Cell Endocrinol,2000;161
(1-2)
: 25-30.
[28] Ganesh V, Venkatesan V, Koshy T, Reddy SN, Muthumuthiah S, Paul SFD. Association of estrogen, progesterone and follicle stimulating hormone receptor polymorphisms with in vitro fertilization outcomes.Syst Biol Reprod Med,2018;64
(4)
: 260-265.
[29] Colacurci N, De Leo V, Ruvolo G, Piomboni P, Caprio F, Pivonello R, Papaleo E, La Verde E, Depalo R, Lispi M, Longobardi S, Paoli D, Pallotti F, Lombardo F. Recombinant FSH Improves Sperm DNA Damage in Male Infertility: A Phase II Clinical Trial.Front Endocrinol (Lausanne),2018;9
: 383.
[30] Chan Y, Zhu B, Zhang J, Luo Y, Tang W. Associations Between TP53 and MDM2 Polymorphisms and the Follicle-Stimulating Hormone/Luteinizing Hormone Ratio in Infertile Women.Genet Test Mol Biomarkers,2018;22
(7)
: 405-412.
[31] Alizadeh M, Nasebakht A, Valizadeh R, Mohammadi Fallah M, Taghizadeh Afshari A, Rahimi MM, Daneshyar C. A preliminary evaluation of serum level of testosterone, LH, and FSH in patients with varicocele after varicocelectomy as a kidney-related disease.Ther Clin Risk Manag,2018;14
: 1585-1590.
[32] Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk.Hum Reprod,2003;18
(8)
: 1570-1573.
[33] Miyazaki K, Miki F, Uchida S, Masuda H, Uchida H, Maruyama T. Serum estradiol level during withdrawal bleeding as a predictive factor for intermittent ovarian function in women with primary ovarian insufficiency.Endocr J,2015;62
(1)
: 93-99.
[34] Hwang JL, Chen SU, Chen HJ, Chen HF, Yang YS, Chang CH, Seow KM, Tzeng CR, Lin YH. Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients.J Formos Med Assoc,2018;117
(6)
: 535-540.
[35] Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.J Assist Reprod Genet,2018;35
(2)
: 297-307.
[36] Bishop LA, Richter KS, Patounakis G, Andriani L, Moon K, Devine K. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.Fertil Steril,2017;108
(6)
: 980-987.
[37] Chihaoui M, Kanoun F, Chaker F, Yazidi M, Bouchrit K, Mizouni H, Feki M, Kharrat M, Slimane H. Testicular adrenal rest tumours in young adult males with congenital adrenal hyperplasia: prevalence and impact on testicular function.Andrologia,2016;48
(1)
: 45-50.
[38] Hart RJ, Doherty DA, McLachlan RI, Walls ML, Keelan JA, Dickinson JE, Skakkebaek NE, Norman RJ, Handelsman DJ. Testicular function in a birth cohort of young men.Hum Reprod,2015;30
(12)
: 2713-2724.
[39] Zheng J, Mao J, Cui M, et al. Novel FSHβ mutation in a male patient with isolated FSH deficiency and infertility.Eur J Med Genet,2017;60
(6)
: 335-339.
[40] Wang H, Chen X, Zhang X, Zhang W, Li Y, Yin H, Shao H, Chen G. Comparative Assessment of Glycosylation of a Recombinant Human FSH and a Highly Purified FSH Extracted from Human Urine.J Proteome Res,2016;15
(3)
: 923-932.
[41] Zhang M, Tong G, Liu Y, Mu Y, Weng J, Xue Y, Luo Z, Xue Y, Shi L, Wu X, Sun S, Zhu Y, Cao Y, Zhang J, Huang H, Niu B, Li H, Guo Q, Gao Y, Li Z, Ning G, Zhu D, Li X; HHIS Study Group. Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism.J Clin Endocrinol Metab,2015;100
(6)
: 2449-2455.
[42] Barriere P, Porcu-Buisson G, Hamamah S. Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis.Appl Health Econ Health Policy,2018;16
(1)
: 65-77.
[43] Barrenetxea G, García-Velasco JA, Aragón B, Osset J, Brosa M, López-Martínez N, Coroleu B. Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.Reprod Biomed Soc Online,2018;5
: 46-59.
[44] Mendret-Pellerin S, Leperlier F, Reignier A, Lefebvre T, Barrière P, Fréour T. A pilot study comparing corifollitropin alfa associated with hp-HMG versus high dose rFSH antagonist protocols for ovarian stimulation in poor responders.Hum Fertil (Camb),2018 ;8
(21)
: 1-8.
[45] Abd-Elaziz K, Duijkers I, Stöckl L, Dietrich B, Klipping C, Eckert K, Goletz S. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.Hum Reprod,2017;32
(8)
: 1639-1647.
[46] OO General. Bone Health and Osteoporosis: A Report of the Surgeon General.Office of the Surgeon General,2004;4
(3)
: 379-382.
[47] Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass .Cell ,2006 ;125
: 247-260.
[48] Imai Y. Bone metabolism by sex hormones and gonadotropins .Clin Calcium ,2014 ;24
(6 )
: 815-819.
[49] Sowers MR, Zheng H, Greendale GA, et al. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity .J Clin Endocrinol Metab ,2013 ;98
: 2854-2863.
[50] Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition .J Clin Endocrinol Metab ,2006 ;91
: 1261-1267.
[51] Xu ZR, Wang AH, Wu XP, et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women .Clin Chim Acta ,2009 ;400
: 8-13.
[52] Zhu LL, Tourkova I, Yuen T, et al. Blocking FSH action attenuates osteoclastogenesis .Biochem Biophys Res Commun ,2012 ;422
: 54-58.
[53] Zaidi M, Blair HC, Iqbal J, et al. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition. Curr Rheumatol Rep,2009;11
: 191-195.
[54] Siraj A, Desestret V, Antoine M, et al. Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases.BMC Cancer,2013;13
: 246.
[55] Ide H, Terado Y, Sakamaki K, et al. Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer.Prostate Int,2013;1
(3)
: 109-112.
[56] Radu A, Pichon C, Camparo P, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels.N Engl J Med,2010;363
: 1621-1630.
[57] Planeix F, Siraj MA, Bidard FC, et al. Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.J Exp Clin Cancer Res,2015;34
: 12.
[58] Pawlikowski M, Radek M, Jaranowska M, et al. Expression of follicle stimulating hormone receptors in pituitary adenomas - a marker of tumor aggressiveness? .Endokrynol Pol ,2014 ;65
(6 )
: 469 -471 .